2U3:FRA
Alcon AG
68,50 €
arrow_upward
+1,39%(+0,94) 1 D.
11-05, 08:03:11 GMT+1 · EUR
search
Visi simboliai
| Simbolis | Kaina | Keisti | Pokytis, % |
|---|
insights_autoGeneruojamos svarbiausios „2U3“ įžvalgos...
Atidaryti
68,50 €
Aukšta
68,50 €
Žema
68,50 €
Rinkos kapitalizacija
31,23 mlrd.
Vid. kiekis
221,00
Apimtis
0,00
52 sav. aukšta
73,96 €
52 sav. žema
51,78 €
Darbuotojų skaičius
25 tūkst.
Atidaryti
68,50 €
Aukšta
68,50 €
Žema
68,50 €
Rinkos kapitalizacija
31,23 mlrd.
Vid. kiekis
221,00
Apimtis
0,00
52 sav. aukšta
73,96 €
52 sav. žema
51,78 €
Darbuotojų skaičius
25 tūkst.
Naujienų istorijos
Iš žiniatinklio šaltinių ir naujienų partnerių
Yahoo Finance
·
prieš 7 valandas
Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Yahoo Finance
·
prieš 9 valandas
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
Yahoo Finance
·
prieš 2 dienas
Alcon Inc. (ALC) Stock Forecasts
Investing.com
·
prieš 3 dienas
Needham reiterates Alcon stock rating on Neurotech acquisition
Profilis
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Apie „Alcon AG“
Generalinis direktoriusDavid J. Endicott
Darbuotojai25 tūkst.
Įkurta1945
Pagrindinė būstinėŽeneva, Ženeva, Šveicarija
SektoriusHealth Care
Industry-
Svetainėalcon.com